Abbott Laboratories (XSWX:ABT) Dividends Received


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF76.00
GF Value CHF103.55
View Full Analysis

What is Abbott Laboratories Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF76.00 is trading 26.6% below its estimated GF Value™ of CHF103.55.

Key valuation signals for XSWX:ABT:

  • Dividends Received:
  • GF Value™: CHF103.55 vs. price of CHF76.00 (26.6% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.00
Price
CHF103.55
GF Value